Noel Servagent
Overview
Explore the profile of Noel Servagent including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
33
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bogaerts E, Saade G, Macaeva E, Chiavassa S, Evin M, Haddad F, et al.
Radiother Oncol
. 2025 Mar;
:110848.
PMID: 40086473
Background And Purpose: Ultra-high dose rate (UHDR) irradiation induces less normal tissues toxicities compared to conventional dose rate (CONV) irradiation. We aimed to assess whether UHDR and CONV proton irradiation...
2.
Fois G, Tran H, Fiegel V, Blain G, Chiavassa S, Craff E, et al.
Med Phys
. 2024 Jul;
51(10):7500-7510.
PMID: 38976841
Background: Radiobiological effectiveness of radiation in cancer treatment can be studied at different scales (molecular till organ scale) and different time post irradiation. The production of free radicals and reactive...
3.
Evin M, Koumeir C, Bongrand A, Delpon G, Haddad F, Mouchard Q, et al.
Phys Med
. 2024 Mar;
120:103332.
PMID: 38518627
As part of translational research projects, mice may be irradiated on radiobiology platforms such as the one at the ARRONAX cyclotron. Generally, these platforms do not feature an integrated imaging...
4.
Ghannam Y, Chiavassa S, Saade G, Koumeir C, Blain G, Delpon G, et al.
Radiother Oncol
. 2023 Jul;
187:109820.
PMID: 37516363
The ability to reduce toxicity of ultra-high dose rate (UHDR) helium ion irradiation has not been reported in vivo. Here, we tested UHDR helium ion irradiation in an embryonic zebrafish...
5.
Saade G, Bogaerts E, Chiavassa S, Blain G, Delpon G, Evin M, et al.
Adv Radiat Oncol
. 2022 Dec;
8(2):101124.
PMID: 36578276
Purpose: Recently, ultrahigh-dose-rate radiation therapy (UHDR-RT) has emerged as a promising strategy to increase the benefit/risk ratio of external RT. Extensive work is on the way to characterize the physical...
6.
Blain G, Vandenborre J, Villoing D, Fiegel V, Fois G, Haddad F, et al.
Radiat Res
. 2022 Jun;
198(3):318-324.
PMID: 35675499
During ultra-high dose rate (UHDR) external radiation therapy, healthy tissues appear to be spared while tumor control remains the same compared to conventional dose rate. However, the understanding of radiochemical...
7.
Villoing D, Koumeir C, Bongrand A, Guertin A, Haddad F, Metivier V, et al.
Med Phys
. 2022 Feb;
49(4):2732-2745.
PMID: 35179234
Purpose: The ARRONAX cyclotron facility offers the possibility to deliver proton beams from low to ultra-high dose rates (UHDR). As a good control of the dosimetry is a prerequisite of...
8.
Bongrand A, Koumeir C, Villoing D, Guertin A, Haddad F, Metivier V, et al.
Cancers (Basel)
. 2021 Apr;
13(8).
PMID: 33920758
Proton therapy (PRT) is an irradiation technique that aims at limiting normal tissue damage while maintaining the tumor response. To study its specificities, the ARRONAX cyclotron is currently developing a...
9.
Koumeir C, De Nadal V, Cherubini R, Cherel M, Garrido E, Gouard S, et al.
Radiat Prot Dosimetry
. 2019 Jan;
183(1-2):270-273.
PMID: 30668799
The cyclotron ARRONAX can deliver different types of particles (protons, deuterons, alpha-particles) in an energy range up to 68 MeV. One of its six experimental halls is dedicated to studying...